Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | AGXT | P21549 | 2/20 | 0.42 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.42 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.42 |
| ▸ | HTR3B | O95264 | 1/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.42 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | PNMT | P11086 | 2/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15413373 | 0.91 | TAAR1 (0.46) | TAAR1CYP3A4IDO1AGXTAOC3 | |
| SCHEMBL19438938 | 0.87 | CHRM2 (0.47) | TAAR1CHRM2 | |
| SCHEMBL21268599 | 0.82 | IDO1 (0.42) | IDO1 | |
| SCHEMBL3168839 | 0.82 | GABRA1 (0.47) | TAAR1CHRM2CHRM1CHRM3 | |
| SCHEMBL21068770 | 0.82 | DUT (0.37) | IDO1 | |
| SCHEMBL11482682 | 0.82 | DUT (0.37) | IDO1CHRM2CHRM1CHRM3 | |
| SCHEMBL3643273 | 0.82 | TAAR1 (0.44) | TAAR1IDO1AGXTMAOB | |
| SCHEMBL21367138 | 0.81 | CYP3A4 (0.56) | TAAR1CYP3A4IDO1AGXTMAOB | |
| SCHEMBL30859481 | 0.81 | DUT (0.40) | TAAR1CYP3A4IDO1AGXTAOC3 | |
| SCHEMBL2252126 | 0.81 | IDO1 (0.53) | IDO1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1325011-A2 | METHODS AND COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | ELI LILLY AND COMPANY (US) | 2003-07-09 | — | — | EP | disclosed |
| WO-2002028861-A2 | METHODS AND COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | ELI LILLY AND COMPANY (US) | 2002-04-11 | — | — | WO | disclosed |